First Time Loading...

Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 010 JPY -0.49% Market Closed
Updated: May 4, 2024

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on May 4, 2024.

Estimated DCF Value of one 4974 stock is 614.01 JPY. Compared to the current market price of 1 010 JPY, the stock is Overvalued by 39%.

DCF Value
Base Case
614.01 JPY
Overvaluation 39%
DCF Value
Price
Worst Case
Base Case
Best Case
614.01
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 614.01 JPY

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 17.2B JPY. The present value of the terminal value is 56.8B JPY. The total present value equals 73.9B JPY.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 73.9B JPY
Equity Value 73.9B JPY
/ Shares Outstanding 120.4m
4974 DCF Value 614.01 JPY
Overvalued by 39%

You are using the equity valuation model. In this approach, further calculations for converting firm value to equity value are not required. The present value, obtained in the present value calculation block, already represents the equity value.

The DCF value per share is derived by dividing the present value by the number of shares:

Present Value
73.9B JPY
/
Number of Shares
120.4m
=
DCF Value
614.01 JPY

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
51.3B 54.3B
Net Income
1.9B 4.3B

See Also

Discover More

What is the DCF value of one 4974 stock?

Estimated DCF Value of one 4974 stock is 614.01 JPY. Compared to the current market price of 1 010 JPY, the stock is Overvalued by 39%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Takara Bio Inc's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 73.9B JPY.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 614.01 JPY per share.

//